SE7414127L - - Google Patents

Info

Publication number
SE7414127L
SE7414127L SE7414127A SE7414127A SE7414127L SE 7414127 L SE7414127 L SE 7414127L SE 7414127 A SE7414127 A SE 7414127A SE 7414127 A SE7414127 A SE 7414127A SE 7414127 L SE7414127 L SE 7414127L
Authority
SE
Sweden
Prior art keywords
flowing
agent
melting
ingredients
cellulose
Prior art date
Application number
SE7414127A
Other languages
English (en)
Inventor
D Voegele
E Schraven
K Resag
J Ostrowski
Original Assignee
Cassella Farbwerke Mainkur Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cassella Farbwerke Mainkur Ag filed Critical Cassella Farbwerke Mainkur Ag
Publication of SE7414127L publication Critical patent/SE7414127L/

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
SE7414127A 1973-11-17 1974-11-11 SE7414127L ( )

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2357503A DE2357503A1 (de) 1973-11-17 1973-11-17 Verfahren zur herstellung von festen carbocromen-hydrochlorid enthaltenden praeparaten

Publications (1)

Publication Number Publication Date
SE7414127L true SE7414127L ( ) 1975-05-20

Family

ID=5898400

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7414127A SE7414127L ( ) 1973-11-17 1974-11-11

Country Status (14)

Country Link
JP (1) JPS5088216A ( )
AU (1) AU7537774A ( )
BE (1) BE822320A ( )
DD (1) DD114753A5 ( )
DE (1) DE2357503A1 ( )
DK (1) DK585974A ( )
FI (1) FI327174A ( )
FR (1) FR2251563B3 ( )
GB (1) GB1442951A ( )
IL (1) IL46064A0 ( )
NL (1) NL7414678A ( )
NO (1) NO744056L ( )
SE (1) SE7414127L ( )
ZA (1) ZA747334B ( )

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1552416A (en) * 1975-08-12 1979-09-12 Beecham Group Ltd Pharmaceutical compositions
GB1572226A (en) * 1977-11-03 1980-07-30 Hoechst Uk Ltd Pharmaceutical preparations in solid unit dosage form
EP1019039B1 (en) * 1997-10-03 2001-12-05 Warner-Lambert Company Compressed nitroglycerin tablet and its method of manufacture
DE10029201A1 (de) 2000-06-19 2001-12-20 Basf Ag Verfahren zur Herstellung fester oraler Darreichungsformen mit retardierender Wirkstoffreisetzung
DE10247037A1 (de) 2002-10-09 2004-04-22 Abbott Gmbh & Co. Kg Herstellung von festen Dosierungsformen unter Verwendung eines vernetzten nichtthermoplastischen Trägers
CN114831950B (zh) * 2022-04-29 2023-05-05 广州新济药业科技有限公司 硝酸甘油包覆物、硝酸甘油舌下片及其制备方法

Also Published As

Publication number Publication date
FR2251563B3 ( ) 1977-08-12
FR2251563A1 ( ) 1975-06-13
ZA747334B (en) 1975-12-31
IL46064A0 (en) 1975-02-10
DK585974A ( ) 1975-07-14
DE2357503A1 (de) 1975-05-28
GB1442951A (en) 1976-07-21
JPS5088216A ( ) 1975-07-15
NO744056L ( ) 1975-06-16
AU7537774A (en) 1976-05-20
NL7414678A (nl) 1975-05-21
FI327174A ( ) 1975-05-18
BE822320A (fr) 1975-05-20
DD114753A5 ( ) 1975-08-20

Similar Documents

Publication Publication Date Title
US3065143A (en) Sustained release tablet
CA2312710C (en) Sustained release formulation containing three different types of polymers and tablet formed therefrom
US4353887A (en) Divisible tablet having controlled and delayed release of the active substance
CA1249519A (en) Compressible starches as binders for tablets or capsules
US3965256A (en) Slow release pharmaceutical compositions
US4235870A (en) Slow release pharmaceutical compositions
KR960005140B1 (ko) 서방성 매트릭스 제형
GB2207353A (en) Controlled release formulation
RU2166936C2 (ru) Способ получения дозировочных единиц путем мокрой грануляции
JPS6440424A (en) Delay release type acetaminophen composition for oral administration and manufacture
PT91442B (pt) Forma de dosagem de libertacao controlada compreendendo diferentes eteres de celulose
CA2018167A1 (en) Sustained release pharmaceutical tablet
DK74187D0 (da) Praeparat til langsom frigivelse samt fremgangsmaade til fremstilling deraf
YU31599A (sh) Brzo oslobadjajući i za ukus maskirajući farmaceutski oblik doze
SE8404804L (sv) Forfarande for framstellning av farmaceutiska kompositioner med fordrojd frigoring och med en hog halt aktiv bestandsdel
SE7414127L ( )
GB1601833A (en) Antacid formulation
KR0177493B1 (ko) 단사정계 결정구조를 갖고 감열, 감광 및 감습성이 있는 활성성분을 함유하는 정제의 제조방법
ATE17650T1 (de) Trockenpulverisierte n-acetyl-p-aminophenolzusammensetzungenund verfahren zu deren herstellung.
EP0013131A2 (en) Pharmaceutical composition in solid dosage form, and process for its production
EP0255725A2 (en) Sustained-release multi-granule tablet
EP0295212A3 (en) Process for preparing a pharmaceutical composition
JPH02286621A (ja) 経口コレステロール低下剤
CA1243956A (en) Process for preparing spray-dried powders containing a water-soluble vitamin and powders prepared thereby
US3917812A (en) Compositions and method for diagnosing diseases of the pancreas